尼泊尔卢比1
吡格列酮
线粒体生物发生
TFAM公司
巨噬细胞极化
过氧化物酶体增殖物激活受体
M2巨噬细胞
SOD2
过氧化物酶体增殖物激活受体γ
肿瘤坏死因子α
败血症
炎症
免疫学
生物
化学
癌症研究
受体
氧化应激
医学
线粒体
巨噬细胞
内分泌学
内科学
细胞生物学
超氧化物歧化酶
糖尿病
生物化学
体外
2型糖尿病
作者
Jing Tang,Wenzhu Dong,Dan Wang,Qin Deng,Honggang Guo,Guibao Xiao
标识
DOI:10.1590/1414-431x2024e13235
摘要
The imbalance between pro-inflammatory M1 and anti-inflammatory M2 macrophages plays a critical role in the pathogenesis of sepsis-induced acute lung injury (ALI). Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) may modulate macrophage polarization toward the M2 phenotype by altering mitochondrial activity. This study aimed to investigate the role of the PGC-1α agonist pioglitazone (PGZ) in modulating sepsis-induced ALI. A mouse model of sepsis-induced ALI was established using cecal ligation and puncture (CLP). An in vitro model was created by stimulating MH-S cells with lipopolysaccharide (LPS). qRT-PCR was used to measure mRNA levels of M1 markers iNOS and MHC-II and M2 markers Arg1 and CD206 to evaluate macrophage polarization. Western blotting detected expression of peroxisome proliferator-activated receptor gamma (PPARγ) PGC-1α, and mitochondrial biogenesis proteins NRF1, NRF2, and mtTFA. To assess mitochondrial content and function, reactive oxygen species levels were detected by dihydroethidium staining, and mitochondrial DNA copy number was measured by qRT-PCR. In the CLP-induced ALI mouse model, lung tissues exhibited reduced PGC-1α expression. PGZ treatment rescued PGC-1α expression and alleviated lung injury, as evidenced by decreased lung wet-to-dry weight ratio, pro-inflammatory cytokine secretion (tumor necrosis factor-α, interleukin-1β, interleukin-6), and enhanced M2 macrophage polarization. Mechanistic investigations revealed that PGZ activated the PPARγ/PGC-1α/mitochondrial protection pathway to prevent sepsis-induced ALI by inhibiting M1 macrophage polarization. These results may provide new insights and evidence for developing PGZ as a potential ALI therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI